ARPA-H Georgia Coalition (AGC)

Georgia is competing for the headquarters of the ARPA-H

What is ARPA-H?

The Biden Administration and Congress established the Advanced Research Projects Agency for Health (ARPA-H) to accelerate biomedical research and deliver health breakthroughs for all patients. The decision of where to headquarter the first federal agency dedicated to accelerating health innovations has not yet been made.


President Biden proposed the creation of the Advanced Research Projects Agency for Health (ARPA-H) to improve the U.S. government’s ability to speed biomedical and health research. Public Law 117-103 was enacted on March 15, 2022, authorizing the establishment of ARPA-H within the U.S. Department of Health and Human Services.


Source and More information here.


ARPA-H Congressional Action & Select Policy Issues

What is the mission of ARPA-H?

1. To push the limits of biomedical and health research to diagnose and cure major diseases (including cancer, heart disease, diabetes, Alzheimer’s disease, and infectious diseases).


2. To ensure that medical breakthroughs are accessible and maximally benefit the American people, especially those who are disproportionally affected by health inequities.


3. To work with global partners to solve our global and national health care challenges since disease and pathogens know no geographic boundaries.

Why Georgia?

  1. “If headquartered in Georgia, ARPA-H would be championed and embraced by our world-class talent, dynamic commercial technology sector, and rich public health research legacy. We believe Georgia’s institutions provide the best partners for ARPA-H to push the limits of biomedical and health research, ensure accessibility of medical breakthroughs, and engage global partners.” -Georgia Congressional delegation letter, June 21, 2022

Diverse and robust talent pipeline

Georgia’s top-ranked institutions of higher learning including Georgia’s HBCUs, our universities, research institutions, schools of engineering, and medical schools are already breaking new ground in biomedical and health research.

Equitable impact of research

ARPA-H would be surrounded and nurtured by health researchers and practitioners who confront health disparities across racial, socioeconomic, and geographic divides.

Global connectivity

As home to the CDC, NGOs, and institutions with a track record of facing health challenges domestically and abroad, Georgia has developed unique, globally-connected infrastructure ideal for ARPA-H.

ARPA-H Georgia Coalition (AGC) - Core Members

Russell Medford, MD, PhD (Chair, AGC); Chair and CEO, Covanos, Inc.; Chair, Board of Directors, Center for Global Health Innovation

Maria Thacker-Goethe, CEO

Deborah Bruner, RN, PhD FAAN, SVP of Research

H. Lee Herron, DVM, VP, Venture Development

Chaouki T. Abdallah, MS, PhD, EVP of Research

Tim Denning, PhD, Vice President for Research & Economic Development

Leanna K. Brown, VP Business Climate & Talent Dev

David Hartnett, Chief Economic Development Officer

Jean R. Sumner, BSN, MSN, MD, Dean of School of Medicine

James Lillard, PhD, Senior Associate Dean

David A. Ross, ScD, President and CEO

Clark Dean, Executive Managing Director

Support Provided By:

Baker Donelson:


Sheila P. Burke, Senior Public Policy Advisor

Rob Gardner, Public Policy Advisor

Linda A. Klein, JD, Partner

Michelle Williams, JD, Partner

Press Inquiries:

Main Contact:

Leanna Brown

Metro Atlanta Chamber Vice President


AGC in the News

The Center for Global Health Innovation’s mission is to advance global and national health equity by promoting and facilitating partnerships to drive impactful innovation. By acting as a trusted convener, we strive to be an action-oriented community change agent and convene for a purpose to move people and communities forward on some of their most intractable issues.